Berkeley Lights company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

berkeleylights.com

Founded Year

2011

Stage

IPO | IPO

Total Raised

$223.68M

Date of IPO

7/17/2020

Market Cap

0.33B

Stock Price

4.98

About Berkeley Lights

Berkeley Lights (NASDAQ: BLI) is a Digital Cell Biology company that has developed a nanoscale technology that accelerates drug discovery and development processes through the combination of bioscience, technology, and information.

Berkeley Lights Headquarter Location

5858 Horton Street Suite 320

Emeryville, California, 94608,

United States

510-858-2855

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Berkeley Lights

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Berkeley Lights is included in 2 Expert Collections, including Synthetic Biology.

S

Synthetic Biology

238 items

Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.

B

Biopharma Tech

838 items

Berkeley Lights Patents

Berkeley Lights has filed 105 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • Microfluidics
  • Fluid dynamics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/18/2014

5/3/2022

Cell biology, Molecular biology, Genetics, Biotechnology, DNA

Grant

Application Date

12/18/2014

Grant Date

5/3/2022

Title

Related Topics

Cell biology, Molecular biology, Genetics, Biotechnology, DNA

Status

Grant

Latest Berkeley Lights News

Glenview Capital added Valvoline, exited Amgen, expanded position in US Foods, narrowed stake in Bausch Health

May 17, 2022

Larry Robbins and Mark Horowitz owned fund, Glenview Capital in its recent 13F filing disclosed newly acquired stakes in Valvoline ( VVV ) with 1.7M shares, Berkeley Lights ( BLI ) with 1.19M shares, Las Vegas Sands ( LVS ) with 1M shares, Meta Platforms ( FB ) with 0.08M shares. The fund exited positions in Dun & Bradstreet ( DNB ), Willis Towers Watson ( WTW ), Amgen ( AMGN ) and Humana ( HUM ) While stakes were increased in ironSource ( IS ) to 7M shares from 1.97M shares, US Foods ( USFD ) to 4.4M shares from 1.62M DXC Technology ( DXC ) to 7.6M from 4.99M shares, Uber ( UBER ) to 3.84M from ~2.53M shares, Fiserv ( FISV ) to 2.14M from 0.5M shares. The fund slashed stakes in Bausch Health ( BHC ), Endo ( ENDP ), Tenet Healthcare ( THC ), McKesson ( MCK ), FMC ( FMC ), DaVita ( DVA ). To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Berkeley Lights Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Berkeley Lights Rank

  • When was Berkeley Lights founded?

    Berkeley Lights was founded in 2011.

  • Where is Berkeley Lights's headquarters?

    Berkeley Lights's headquarters is located at 5858 Horton Street, Emeryville.

  • What is Berkeley Lights's latest funding round?

    Berkeley Lights's latest funding round is IPO.

  • How much did Berkeley Lights raise?

    Berkeley Lights raised a total of $223.68M.

  • Who are Berkeley Lights's competitors?

    Competitors of Berkeley Lights include CellChorus.

You May Also Like

M
Molecular Devices Corporation

Molecular Devices is a leading developer of high-performance, bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. Our systems enable pharmaceutical and biotechnology companies to leverage advances in genomics and combinatorial chemistry by facilitating the rapid and cost effective identification and evaluation of drug candidates. Our instrument systems are based on our advanced core technologies which integrate our expertise in engineering, molecular and cell biology and chemistry. Our systems are fundamental tools for drug discovery and life science research, and our MAXline series of microplate readers and our FLIPR Cell Analysis systems are market share leaders in their respective markets.

CellChorus Logo
CellChorus

CellChorus provides a dynamic analysis of single cells. The company’s TIMING platform applies visual AI to evaluate cell activation, killing, and movement as a function of time in order to maximize our understanding of cellular function, state, and phenotype.

L
LJL Biosystems

LJL Biosystems, Inc. developed and manufactured automated instrumentation systems for clinical, research and drug development applications. The company was acquired by Molecular Devices Corporation (Nasdaq: MDCC) in August of 2000.

Agilent Technologies Logo
Agilent Technologies

Agilent Technologies (NYSE: A) provides instruments, software, services, and consumables for the entire laboratory workflow, serving the life sciences, diagnostics, and applied chemical markets.

Sartorius Logo
Sartorius

The Sartorius Group is an international partner of life science research and the biopharmaceutical industry. With laboratory instruments and consumables, the Group's Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.